A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking

A novel infectious disease, caused by 2019 Novel Coronavirus (2019-nCoV) is responsible for the recent outbreak of severe respiratory disease. The 2019-nCoV spread rapidly and reaching epidemic proportions in many countries of the world. ACE2 was identified as a key receptor for 2019-nCoV infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghili, Zahra Sadat, Mirzaei, Seyed Abbas, Banitalebi-Dehkordi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720268/
https://www.ncbi.nlm.nih.gov/pubmed/34963881
http://dx.doi.org/10.1186/s40709-020-00129-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720268/
https://www.ncbi.nlm.nih.gov/pubmed/34963881
http://dx.doi.org/10.1186/s40709-020-00129-y

Ejemplares similares